CVI988 (Rispens), an avirulent strain of Marek's disease virus, is the most widely used vaccine against Marek's disease. The kinetics of replication of CVI988 was examined in tissues of chickens vaccinated at either 1 day or 14 days of age and sampled regularly up to 28 days post-vaccination. Age at vaccination had no significant effect on the kinetics of CVI988 virus replication. During the cytolytic phase of infection (1–7 days), virus levels peaked in the spleen, bursa and thymus with very close correlation among these organs. Virus load in peripheral blood lagged behind and did not reach high levels. Significant numbers of virus genomes were detected in the feather tips only after 7 days, but subsequently rose to levels almost 103-fold greater than in the other tissues. This is the first accurate quantitative data for kinetics of CVI988 replication in a variety of tissues. There was good correlation between data from virus isolation and PCR, with real-time PCR being the preferred method for rapid, accurate and sensitive quantification of virus. Feathers were ideal for non-invasive sampling to detect and measure CVI988 in live chickens and, from 10 days onwards, virus load in feather tips was predictive of virus load in lymphoid tissues where immune responses will occur. The potential for real-time PCR analysis of feather samples for further investigation of the mechanism of vaccinal protection, and to assist optimization of vaccination regimes, is discussed.
BaatenB. J.,
ButterC.,
DavisonT. F.2004; Study of host–pathogen interactions to identify sustainable vaccine strategies to Marek's disease. Vet Immunol Immunopathol 100:165–177[CrossRef]
BaigentS. J.,
DavisonF.1999; Development and composition of lymphoid lesions in the spleens of Marek's disease virus-infected chickens: association with virus spread and the pathogenesis of Marek's disease. Avian Pathol 28:287–300[CrossRef]
BaigentS. J.,
DavisonT. F.2004; Marek's disease virus: biology and life cycle. In Marek's Disease: an Evolving Problem pp 62–77 Edited by
DavisonF.,
NairV.
Oxford: Elsevier;
BaigentS. J.,
RossL. J. N.,
DavisonT. F.1998; Differential susceptibility to Marek's disease is associated with differences in number, but not phenotype or location, of pp38+ lymphocytes. J Gen Virol 79:2795–2802
BaigentS. J.,
PetherbridgeL. J.,
HowesK.,
SmithL. P.,
CurrieR. J. W.,
NairV. K.2005; Absolute quantitation of Marek's disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. J Virol Methods 123:53–64[CrossRef]
BeckerY.,
TaborE.,
AsherY.,
DavidsonI.,
MalkinsonM.,
WitterR. L.1993; PCR detection of amplified 132 bp repeats in Marek's disease virus type 1 (MDV-1) DNA can serve as an indicator for critical genomic rearrangement leading to the attenuation of virus virulence. Virus Genes 7:277–287[CrossRef]
BublotM.,
SharmaJ.2004; Vaccination against Marek's disease. In Marek's Disease: an Evolving Problem pp 168–185 Edited by
DavisonF.,
NairV.
Oxford: Elsevier;
BuscagliaC.,
CalnekB. W.,
SchatK. A.1988; Effect of immunocompetence on the establishment and maintenance of latency with Marek's disease herpesvirus. J Gen Virol 69:1067–1077[CrossRef]
CalnekB. W.,
AdldingerH. K.,
KahnD. E.1970; Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Dis 14:219–233[CrossRef]
DavidsonI.,
BorenshtainR.2003; Novel applications of feather tip extracts from MDV-infected chickens; diagnosis of commercial broilers, whole genome separation by PFGE and synchronic mucosal infection. FEMS Immunol Med Microbiol 38:199–203[CrossRef]
DavidsonI.,
BorenshtainR.,
WeismanY.2002; Molecular identification of the Marek's disease virus vaccine strain CVI988 in vaccinated chickens. J Vet Med B Infect Dis Vet Public Health 49:83–87[CrossRef]
de BoerG. F.,
GroenendalJ. E.,
BoerrigterH. M.,
KokG. L.,
PolJ. M.1986; Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains. Avian Dis 30:276–283[CrossRef]
FukuchiK.,
TanakaA.,
SchiermanL. W.,
WitterR. L.,
NonoyamaM.1985; The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proc Natl Acad Sci U S A 82:751–754[CrossRef]
GimenoI. M.,
WitterR. L.,
HuntH. D.,
ReddyS. M.,
ReedW. M.2004; Biocharacteristics shared by highly protective vaccines against Marek's disease. Avian Pathol 33:59–68
HandbergK. J.,
NielsenO. L.,
JorgensenP. H.2001; The use of serotype 1- and serotype 3-specific polymerase chain reaction for the detection of Marek's disease virus in chickens. Avian Pathol 30:243–249[CrossRef]
LeeS. I.,
OhashiK.,
MorimuraT.,
SugimotoC.,
OnumaM.1999; Re-isolation of Marek's disease virus from T cell subsets of vaccinated and non-vaccinated chickens. Arch Virol 144:45–54[CrossRef]
MalkinsonM.,
DavidsonI.,
StrengerC.,
WeismanY.,
MarayT.,
LevyH.,
BeckerY.1989; Kinetics of the appearance of Marek's disease virus DNA and antigens in the feathers of chickens. Avian Pathol 18:735–744[CrossRef]
MaotaniK.,
KanamoriA.,
IkutaK.,
UedaS.,
KatoS.,
HiraiK.1986; Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage. J Virol 58:657–660
MorimuraT.,
OhashiK.,
SugimotoC.,
OnumaM.1998; Pathogenesis of Marek's disease (MD) and possible mechanisms of immunity induced by MD vaccine. J Vet Med Sci 60:1–8[CrossRef]
RispensB. H.,
Van VlotenJ.,
MastenbroekN.,
MaasH. J. L.,
SchatK. A.1972; Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis 16:108–125[CrossRef]
SilvaR. F.1992; Differentiation of pathogenic and non-pathogenic serotype 1 Marek's disease viruses (MDVs) by the polymerase chain reaction amplification of the tandem direct repeats within the MDV genome. Avian Dis 36:521–528[CrossRef]
SilvaR. F.,
ReddyS. M.,
LupianiB.2004; Expansion of a unique region in the Marek's disease virus genome occurs concomitantly with attenuation but is not sufficient to cause attenuation. J Virol 78:733–740[CrossRef]
WitterR. L.,
CalnekB. W.,
BuscagliaC.,
GimenoI. M.,
SchatK. A.2005; Classification of Marek's disease viruses according to pathotype: philosophy and methodology. Avian Pathol 34:75–90[CrossRef]
YunisR.,
JarosinskiK. W.,
SchatK. A.2004; Association between rate of viral genome replication and virulence of Marek's disease herpesvirus strains. Virology 328:142–150[CrossRef]